+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Genetic Analysis Market by Technology, Application, End User, Product, Sample Type, Workflow - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6016153
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genetic Analysis Market grew from USD 10.24 billion in 2023 to USD 10.94 billion in 2024. It is expected to continue growing at a CAGR of 6.90%, reaching USD 16.34 billion by 2030.

Genetic analysis encompasses various techniques used to study DNA and genetic code to interpret the genetic basis of diseases and traits. The necessity of genetic analysis has surged with advancements in personalized medicine, where understanding individual genetic make-up is crucial in tailoring effective patient treatments. Key applications include diagnostic testing, pharmacogenomics, oncology, and hereditary genetic testing, which cater to diverse end-users such as hospitals, research institutes, and biotechnology firms. The market is primarily driven by technological advancements, increasing prevalence of genetic disorders, growing awareness, and demand for personalized medicine. The advent of powerful tools like CRISPR and next-generation sequencing (NGS) has made genetic analysis more accessible, driving market growth. The latest potential opportunities lie in expanding applications of genetic analysis in agriculture, forensic science, and prenatal diagnostics. Companies can capitalize on these opportunities by investing in R&D to improve accuracy, speed, and cost-efficiency of genetic analysis tools. However, the market faces challenges such as ethical concerns, high costs of advanced technologies, and regulatory hurdles which can stifle growth. Data privacy concerns and the complex nature of gene editing raise ethical and legal issues, requiring balanced policies to mitigate their impact. Areas of innovation ripe for exploration include AI-integrated analytics for more precise genomic interpretations and developing affordable, portable genetic testing kits, expanding accessibility to resource-limited settings. There is also significant potential in epigenetics and expanding the understanding of non-coding DNA’s role. The genetic analysis market is competitive, characterized by rapid technological evolution and demand for cross-disciplinary expertise. To adapt, businesses should focus on forming strategic partnerships, pursuing niche markets, and continuing investment in developing high-quality, interoperable platforms to support seamless integration into existing healthcare workflows, thereby enhancing business growth and market penetration.

Understanding Market Dynamics in the Genetic Analysis Market

The Genetic Analysis Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expanding role of genetic analysis in personalized healthcare and targeted therapies
    • Government initiatives and funding support for genomic research and public health programs
    • Collaboration between academic institutions and biotech companies fostering genetic research
    • Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
  • Market Restraints
    • Growing concerns regarding the variability and accuracy of genetic testing results
    • Barriers to market entry due to rapid technological advancement and intense competition among key players
  • Market Opportunities
    • Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
    • Development of genetic analysis tools for drug discovery and personalized treatment plans
    • Utilization of genetic insights for precision farming and sustainable agricultural practices
  • Market Challenges
    • Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
    • Limited expertise and workforce in the field of genetic analysis impacting market growth

Exploring Porter’s Five Forces for the Genetic Analysis Market

Porter’s Five Forces framework further strengthens the insights of the Genetic Analysis Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Genetic Analysis Market

External macro-environmental factors deeply influence the performance of the Genetic Analysis Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Genetic Analysis Market

The Genetic Analysis Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Genetic Analysis Market

The Genetic Analysis Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Genetic Analysis Market

The Genetic Analysis Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Analysis Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., BGI Group, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Genewiz, Inc., Genomic Health, Inc., Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Capillary Electrophoresis
    • CRISPR
    • Mass Spectrometry
    • Microarray
    • Next-Generation Sequencing
    • Polymerase Chain Reaction
    • Polymerase Chain Reaction (PCR)
      • Digital PCR
      • Real-Time PCR
    • Single-Cell Genomics
  • Application
    • Agricultural Genetics
    • Animal Genetics
    • Clinical Diagnostics
      • Cancer Diagnostics
      • Genetic Disease Diagnostics
      • Infectious Diseases
    • Forensic Science
    • Pharmaceutical & Biotechnology
    • Research
  • End User
    • Diagnostic Laboratories
    • Forensic Laboratories
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
    • Research Centers & Academic Institutions
  • Product
    • Instruments
    • Reagents & Consumables
    • Software & Services
  • Sample Type
    • Blood
    • Bone
    • Saliva
    • Tissue
  • Workflow
    • Data Analysis
    • Pre-Sequencing
    • Sequencing
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding role of genetic analysis in personalized healthcare and targeted therapies
5.1.1.2. Government initiatives and funding support for genomic research and public health programs
5.1.1.3. Collaboration between academic institutions and biotech companies fostering genetic research
5.1.1.4. Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
5.1.2. Restraints
5.1.2.1. Growing concerns regarding the variability and accuracy of genetic testing results
5.1.2.2. Barriers to market entry due to rapid technological advancement and intense competition among key players
5.1.3. Opportunities
5.1.3.1. Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
5.1.3.2. Development of genetic analysis tools for drug discovery and personalized treatment plans
5.1.3.3. Utilization of genetic insights for precision farming and sustainable agricultural practices
5.1.4. Challenges
5.1.4.1. Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
5.1.4.2. Limited expertise and workforce in the field of genetic analysis impacting market growth
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Genetic Analysis Market, by Technology
6.1. Introduction
6.2. Capillary Electrophoresis
6.3. CRISPR
6.4. Mass Spectrometry
6.5. Microarray
6.6. Next-Generation Sequencing
6.7. Polymerase Chain Reaction
6.8. Polymerase Chain Reaction (PCR)
6.8.1. Digital PCR
6.8.2. Real-Time PCR
6.9. Single-Cell Genomics
7. Genetic Analysis Market, by Application
7.1. Introduction
7.2. Agricultural Genetics
7.3. Animal Genetics
7.4. Clinical Diagnostics
7.4.1. Cancer Diagnostics
7.4.2. Genetic Disease Diagnostics
7.4.3. Infectious Diseases
7.5. Forensic Science
7.6. Pharmaceutical & Biotechnology
7.7. Research
8. Genetic Analysis Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Forensic Laboratories
8.4. Hospitals & Clinics
8.5. Pharmaceutical & Biotechnology Companies
8.6. Research Centers & Academic Institutions
9. Genetic Analysis Market, by Product
9.1. Introduction
9.2. Instruments
9.3. Reagents & Consumables
9.4. Software & Services
10. Genetic Analysis Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Bone
10.4. Saliva
10.5. Tissue
11. Genetic Analysis Market, by Workflow
11.1. Introduction
11.2. Data Analysis
11.3. Pre-Sequencing
11.4. Sequencing
12. Americas Genetic Analysis Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Genetic Analysis Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Genetic Analysis Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GENETIC ANALYSIS MARKET RESEARCH PROCESS
FIGURE 2. GENETIC ANALYSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. GENETIC ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. GENETIC ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENETIC ANALYSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GENETIC ANALYSIS MARKET DYNAMICS
TABLE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SINGLE-CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY AGRICULTURAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY GENETIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 68. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 74. CANADA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. CANADA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 76. CANADA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 78. CANADA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. CANADA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. CANADA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. CANADA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 82. MEXICO GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 84. MEXICO GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. MEXICO GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 116. CHINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. CHINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 118. CHINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. CHINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. CHINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CHINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. CHINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 123. CHINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 124. INDIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. INDIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 126. INDIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. INDIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 128. INDIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. INDIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. INDIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 134. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 140. JAPAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. JAPAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 142. JAPAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. JAPAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. JAPAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. JAPAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 147. JAPAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 182. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 188. THAILAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. THAILAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 190. THAILAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. THAILAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. THAILAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. THAILAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. THAILAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 195. THAILAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 198. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 213. DENMARK GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. DENMARK GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 215. DENMARK GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. DENMARK GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. DENMARK GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. DENMARK GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. DENMARK GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 220. DENMARK GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 221. EGYPT GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. EGYPT GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 223. EGYPT GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. EGYPT GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 228. EGYPT GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 229. FINLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. FINLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 231. FINLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. FINLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 233. FINLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. FINLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. FINLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 236. FINLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 237. FRANCE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. FRANCE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 239. FRANCE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. FRANCE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 241. FRANCE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. FRANCE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. FRANCE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 245. GERMANY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. GERMANY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 247. GERMANY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. GERMANY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 249. GERMANY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. GERMANY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. GERMANY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 252. GERMANY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 255. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 261. ITALY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. ITALY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 263. ITALY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. ITALY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 265. ITALY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ITALY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. ITALY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 268. ITALY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 279. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 285. NORWAY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. NORWAY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 287. NORWAY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. NORWAY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. NORWAY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. NORWAY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. NORWAY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 292. NORWAY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 293. POLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. POLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 295. POLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. POLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 297. POLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. POLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. POLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 300. POLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 301. QATAR GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. QATAR GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 303. QATAR GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. QATAR GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. QATAR GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. QATAR GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. QATAR GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 308. QATAR GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 311. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 313. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 332. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 333. SPAIN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 334. SPAIN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 335. SPAIN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. SPAIN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 337. SPAIN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 338. SPAIN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 339. SPAIN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 340. SPAIN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 343. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 345. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 346. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 347. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 348. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 350. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
TABLE 351. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 353. SWITZERLAND GENETIC ANALYSIS

Companies Mentioned

The leading players in the Genetic Analysis Market, which are profiled in this report, include:
  • 23andMe, Inc.
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Genewiz, Inc.
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Personalis, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information